Essential to increase the use of generics in Europe to maintain comprehensive health care?
INTRODUCTION: Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintai...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2012-12-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/312 |
| _version_ | 1811268552610545664 |
|---|---|
| author | Brian Godman Marion Bennie Christoph Baumgärtel Ljiljana Sović-Brkičić Thomas Burkhardt Jurij Fürst Kristina Garuoliene Miguel Gomes Vanda Markovic-Pekovic Andrew Martin Catherine Sermet Peter Skiold Menno van Woerkom Luka Voncina Lars L. Gustafsson |
| author_facet | Brian Godman Marion Bennie Christoph Baumgärtel Ljiljana Sović-Brkičić Thomas Burkhardt Jurij Fürst Kristina Garuoliene Miguel Gomes Vanda Markovic-Pekovic Andrew Martin Catherine Sermet Peter Skiold Menno van Woerkom Luka Voncina Lars L. Gustafsson |
| author_sort | Brian Godman |
| collection | DOAJ |
| description | INTRODUCTION: Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. OBJECTIVE: To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. METHODOLOGY: A narrative review of published papers combined with case histories. RESULTS: The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. CONCLUSIONS: Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other. |
| first_indexed | 2024-04-12T21:25:06Z |
| format | Article |
| id | doaj.art-df7632e532124a708875c84591b2c311 |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-04-12T21:25:06Z |
| publishDate | 2012-12-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-df7632e532124a708875c84591b2c3112022-12-22T03:16:12ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2012-12-01133S52010.7175/fe.v13i3S.312439Essential to increase the use of generics in Europe to maintain comprehensive health care?Brian Godman0Marion Bennie1Christoph Baumgärtel2Ljiljana Sović-Brkičić3Thomas Burkhardt4Jurij Fürst5Kristina Garuoliene6Miguel Gomes7Vanda Markovic-Pekovic8Andrew Martin9Catherine Sermet10Peter Skiold11Menno van Woerkom12Luka Voncina13Lars L. Gustafsson14Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, SwedenStrathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom 5 Information Services Division, NHS National Services Scotland, Edinburgh, United Kingdom, EH12 9EBAustrian Medicines and Medical Devices Agency, Traisengasse 5, Wien, AustriaDepartment of Drugs and Medical Products, Croatian Institute for Health Insurance, Zagreb, CroatiaHauptverband der Österreichischen Sozialversicherungsträger, Kundmanngasse 21, Wien, AustriaHealth Insurance Institute, Ljubljana, SloveniaMedicines Reimbursement Department, National Health Insurance Fund, Vilnius, LithuaniaINFARMED, Parque da Saúde de Lisboa, Lisboa, PortugalFaculty of Medicine, University of Banja Luka, Banja Luka, Republic Srpska, Bosnia and Herzegovina Ministry of Health and Social Welfare, Banja Luka, Republic Srpska, Bosnia and HerzegovinaNHS Bury, Bury, UKIRDES, 10, rue Vauvenargues, 75018, Paris, FranceDental and Pharmaceuticals Benefits Agency (TLV), Stockholm, SwedenDutch Institute for Rational Use of Medicines, 3527 Utrecht, NetherlandsMinistry of Health, Republic of Croatia, Zagreb, CroatiaDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, SwedenINTRODUCTION: Reforms have been introduced across Europe to increase prescribing efficiency with existing drugs. These include measures to lower prices of generics as well as increase their prescribing versus originators and patented products in a class or related class. This is essential to maintain comprehensive health care in Europe given continued pressures. The alternative is insufficient funds for new innovative drugs and increasing drug volumes with ageing populations. OBJECTIVE: To review the influence of measures and initiatives to increase the prescribing and dispensing of generics at low prices on ambulatory care prescribing efficiency. In view of this, provide guidance as authorities strive to introduce further reforms to meet their goals. METHODOLOGY: A narrative review of published papers combined with case histories. RESULTS: The different supply- and demand-side measures have reduced generic prices to as low as 2% to 3% of pre-patent loss prices in some cases as well as appreciably enhanced their utilisation. As a result, prescribing efficiency has increased without compromising care. In some cases, the reforms have led to expenditure actually falling despite appreciably increased volumes. CONCLUSIONS: Increasing use of generics at low prices will help maintain the European ideals of comprehensive and equitable health care. However, countries will continually need to learn from each other.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/312demand-side measureseuropegenericspharmaceuticalspricingsupply-side measures |
| spellingShingle | Brian Godman Marion Bennie Christoph Baumgärtel Ljiljana Sović-Brkičić Thomas Burkhardt Jurij Fürst Kristina Garuoliene Miguel Gomes Vanda Markovic-Pekovic Andrew Martin Catherine Sermet Peter Skiold Menno van Woerkom Luka Voncina Lars L. Gustafsson Essential to increase the use of generics in Europe to maintain comprehensive health care? Farmeconomia: Health Economics and Therapeutic Pathways demand-side measures europe generics pharmaceuticals pricing supply-side measures |
| title | Essential to increase the use of generics in Europe to maintain comprehensive health care? |
| title_full | Essential to increase the use of generics in Europe to maintain comprehensive health care? |
| title_fullStr | Essential to increase the use of generics in Europe to maintain comprehensive health care? |
| title_full_unstemmed | Essential to increase the use of generics in Europe to maintain comprehensive health care? |
| title_short | Essential to increase the use of generics in Europe to maintain comprehensive health care? |
| title_sort | essential to increase the use of generics in europe to maintain comprehensive health care |
| topic | demand-side measures europe generics pharmaceuticals pricing supply-side measures |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/312 |
| work_keys_str_mv | AT briangodman essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT marionbennie essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT christophbaumgartel essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT ljiljanasovicbrkicic essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT thomasburkhardt essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT jurijfurst essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT kristinagaruoliene essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT miguelgomes essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT vandamarkovicpekovic essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT andrewmartin essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT catherinesermet essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT peterskiold essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT mennovanwoerkom essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT lukavoncina essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare AT larslgustafsson essentialtoincreasetheuseofgenericsineuropetomaintaincomprehensivehealthcare |